sacubitril/valsartan (Entresto) In adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.
March 2016 decisions news release The Scottish Medicines Consortium (SMC) has today published advice accepting three new medicines for routine use in NHSScotland.
